Gemadol Retard 100 mg depotkapsler Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

gemadol retard 100 mg depotkapsler

viatris aps - tramadolhydrochlorid - depotkapsler - 100 mg

Gemadol Retard 150 mg depotkapsler Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

gemadol retard 150 mg depotkapsler

viatris aps - tramadolhydrochlorid - depotkapsler - 150 mg

Gemadol Retard 200 mg depotkapsler Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

gemadol retard 200 mg depotkapsler

viatris aps - tramadolhydrochlorid - depotkapsler - 200 mg

Metronidazol "DAK" 500 mg filmovertrukne tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

metronidazol "dak" 500 mg filmovertrukne tabletter

orifarm healthcare a/s - metronidazol - filmovertrukne tabletter - 500 mg

Pyrazinamid "Medic" 500 mg tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

pyrazinamid "medic" 500 mg tabletter

mylan denmark aps - pyrazinamidum - tabletter - 500 mg

Uniloc 100 mg tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

uniloc 100 mg tabletter

takeda pharma a/s - atenolol - tabletter - 100 mg

Uniloc 25 mg tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

uniloc 25 mg tabletter

takeda pharma a/s - atenolol - tabletter - 25 mg

Uniloc 50 mg tabletter Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

uniloc 50 mg tabletter

takeda pharma a/s - atenolol - tabletter - 50 mg

Zejula Evropska unija - danščina - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastiske midler - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Lenalidomide Accord Evropska unija - danščina - EMA (European Medicines Agency)

lenalidomide accord

accord healthcare s.l.u. - lenalidomid - multipelt myelom - immunosuppressiva - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) er indiceret til behandling af voksne patienter med tidligere ubehandlet myelomatose, der ikke er berettiget til transplantation. lenalidomid overenskomst i kombination med dexamethason er indiceret til behandling af myelomatose hos voksne patienter, der har modtaget mindst én tidligere behandling. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).